Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation

• Autor(a) principal: Souza, Thiago Moreno L.
• Data de Publicação: 2023
• Outros Autores: Pinho, Vagner D., Setim, Cristina F., Sacramento, Carolina Q., Marcon, Rodrigo, Rodrigues, Natalia Fintelman, Chaves, Otavio A., Heller, Melina, Temerozo, Jairo Ramos, Ferreira, André C., Mattos, Mayara, Momo, Patrícia B., Dias, Suelen S. G., Gesto, João S. M., Dutra, Filipe Pereira, Viola, João P. B., Queiroz Junior, Celso Martins, Guimarães, Lays Cordeiro, Chaves, Ian Meira, Guimarães, Pedro Pires Goulart, Costa, Vivian Vasconcelos, Teixeira, Mauro Martins, Bou-Habib, Dumith Chequer, Bozza, Patrícia Torres, Aguillón, Anderson R., Siqueira Junior, Jarbas, Macedo Junior, Sergio, Andrade, Edineia L., Fadanni, Guilherme P., Tolouei, Sara E. L., Potrich, Francine B., Santos, Adara A., Marques, Naiani F., Calixto, João B., Rabi, Jaime A.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
• Texto Completo: https://www.arca.fiocruz.br/handle/icict/56575
• topic: COVID-19; SARS-CoV-2; Antiviral Agents; Kinetin; COVID-19; SARS-CoV-2; Antiviral; MB-905; Virus-induced inflammation; Kinetin; COVID-19; SARS-CoV-2; Antiviral Agents; Kinetin

Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.